Lynch & Associates Bristol Myers Squibb CO Transaction History

Lynch & Associates

  • $429 Million
  • Q1 2024

A detailed history of Lynch & Associates transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lynch & Associates holds 8,053 shares of BMY stock, worth $331,139. This represents 0.1% of its overall portfolio holdings.

Number of Shares
8,053
Previous 9,303 13.44%
Holding current value
$331,139
Previous $477,000 8.6%
% of portfolio
0.1%
Previous 0.12%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 09, 2024
SELL
$47.98 - $54.4 $59,974 - $68,000
-1,250 Reduced 13.44%
8,053 $436,000
Q4 2023

Jan 08, 2024
SELL
$48.48 - $57.85 $19,828 - $23,660
-409 Reduced 4.21%
9,303 $477,000
Q3 2023

Oct 24, 2023
BUY
$57.89 - $64.73 $61,942 - $69,261
1,070 Added 12.38%
9,712 $563,000
Q2 2023

Oct 24, 2023
SELL
$63.71 - $70.74 $3,058 - $3,395
-48 Reduced 0.55%
8,642 $552,000
Q2 2023

Jul 13, 2023
SELL
$63.71 - $70.74 $3,058 - $3,395
-48 Reduced 0.55%
8,642 $553,000
Q1 2023

Oct 24, 2023
BUY
$65.71 - $74.53 $3,154 - $3,577
48 Added 0.56%
8,690 $602,000
Q1 2023

Apr 04, 2023
SELL
$65.71 - $74.53 $11,564 - $13,117
-176 Reduced 1.99%
8,690 $602,000
Q4 2022

Oct 24, 2023
SELL
$68.48 - $81.09 $57,934 - $68,602
-846 Reduced 8.71%
8,866 $637,000
Q4 2022

Jan 05, 2023
SELL
$68.48 - $81.09 $8,902 - $10,541
-130 Reduced 1.45%
8,866 $638,000
Q1 2022

Apr 08, 2022
SELL
$61.48 - $73.72 $14,755 - $17,692
-240 Reduced 2.6%
8,996 $657,000
Q4 2021

Jan 11, 2022
BUY
$53.63 - $62.52 $35,932 - $41,888
670 Added 7.82%
9,236 $576,000
Q2 2021

Jul 21, 2021
SELL
$61.91 - $67.42 $19,192 - $20,900
-310 Reduced 3.49%
8,566 $572,000
Q3 2020

Oct 21, 2020
SELL
$57.43 - $63.64 $86,145 - $95,460
-1,500 Reduced 14.46%
8,876 $535,000
Q2 2020

Jul 20, 2020
SELL
$54.82 - $64.09 $88,808 - $103,825
-1,620 Reduced 13.5%
10,376 $610,000
Q1 2020

Apr 28, 2020
BUY
$46.4 - $67.43 $232 - $337
5 Added 0.04%
11,996 $669,000
Q3 2019

Oct 03, 2019
SELL
$42.77 - $50.71 $10,478 - $12,423
-245 Reduced 2.0%
11,991 $608,000
Q2 2019

Jul 19, 2019
SELL
$44.62 - $49.34 $56,533 - $62,513
-1,267 Reduced 9.38%
12,236 $555,000
Q4 2018

Jan 10, 2019
SELL
$48.76 - $63.23 $1,462 - $1,896
-30 Reduced 0.22%
13,503 $702,000
Q2 2018

Jul 09, 2018
SELL
$50.53 - $62.98 $28,549 - $35,583
-565 Reduced 4.01%
13,533 $749,000
Q1 2018

Apr 06, 2018
SELL
$59.92 - $68.98 $98,868 - $113,817
-1,650 Reduced 10.48%
14,098 $892,000
Q4 2017

Jan 04, 2018
SELL
$59.94 - $65.35 $7,192 - $7,841
-120 Reduced 0.76%
15,748 $965,000
Q3 2017

Oct 18, 2017
BUY
$55.23 - $63.74 $876,389 - $1.01 Million
15,868
15,868 $1.01 Million

Others Institutions Holding BMY

# of Institutions
2,557
Shares Held
1.49B
Call Options Held
25.9M
Put Options Held
20M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $87.4B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Lynch & Associates Portfolio

Follow Lynch & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lynch & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Lynch & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email